Back

Cash versus Lotteries: COVID-19 Vaccine Incentives Experiment

Duch, R. M.; Barnett, A.; Filipek, M.; Roope, L.; Violato, M.; Clarke, P.

2021-07-28 health economics
10.1101/2021.07.26.21250865
Show abstract

Governments are considering financial incentives to increase vaccine uptake to end the COVID-19 pandemic. Incentives being offered include cash-equivalents such as vouchers or being entered into lotteries. Our experiment involved random assignment of 1,628 unvaccinated participants in the United States to one of three 45 second informational videos promoting vaccination with messages about: (a) health benefits of COVID-19 vaccines (control); (b) being entered into lotteries; or (c) receiving cash equivalent vouchers. After seeing the control health information video, 16% of individuals wanted information on where to get vaccinated. This compared with 14% of those assigned to the lottery video (odds ratio of 0.82 relative to control: 95% credible interval 0.57-1.17) and 22% of those assigned to the cash voucher video (odds ratio of 1.53 relative to control: 95% credible interval 1.11-2.11). These results support greater use of cash vouchers to promote COVID-19 vaccine uptake and do not support the use of lottery incentives.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
based on 1737 papers
Top 41%
12.6%
2
Journal of Medical Economics
based on 10 papers
Top 0.1%
12.4%
3
American Journal of Preventive Medicine
based on 11 papers
Top 0.1%
10.1%
4
Proceedings of the National Academy of Sciences
based on 100 papers
Top 1%
7.5%
5
Clinical Infectious Diseases
based on 219 papers
Top 6%
5.0%
6
JAMA Network Open
based on 125 papers
Top 4%
4.5%
50% of probability mass above
7
Vaccine
based on 140 papers
Top 2%
4.5%
8
Journal of Medical Internet Research
based on 81 papers
Top 5%
2.9%
9
Scientific Reports
based on 701 papers
Top 52%
2.9%
10
Vaccines
based on 131 papers
Top 2%
2.8%
11
PLOS Medicine
based on 95 papers
Top 6%
2.4%
12
npj Vaccines
based on 18 papers
Top 0.2%
2.3%
13
Social Science & Medicine
based on 15 papers
Top 0.5%
2.2%
14
Preventive Medicine Reports
based on 14 papers
Top 0.4%
2.2%
15
BMJ Open
based on 553 papers
Top 38%
1.8%
16
BMC Public Health
based on 148 papers
Top 15%
1.6%
17
Vaccine: X
based on 16 papers
Top 0.8%
1.3%
18
The Lancet Infectious Diseases
based on 57 papers
Top 5%
1.3%
19
eLife
based on 262 papers
Top 25%
1.2%
20
American Journal of Epidemiology
based on 54 papers
Top 6%
0.8%
21
eClinicalMedicine
based on 55 papers
Top 5%
0.8%
22
Nature Communications
based on 483 papers
Top 41%
0.8%
23
BMJ
based on 49 papers
Top 8%
0.7%
24
BMC Medicine
based on 155 papers
Top 26%
0.7%
25
Journal of General Internal Medicine
based on 19 papers
Top 4%
0.7%
26
Nature Human Behaviour
based on 18 papers
Top 3%
0.7%
27
Nature
based on 58 papers
Top 11%
0.7%
28
Genetics in Medicine
based on 57 papers
Top 6%
0.7%
29
Open Forum Infectious Diseases
based on 124 papers
Top 12%
0.7%
30
PLOS Global Public Health
based on 287 papers
Top 23%
0.7%